SecBot SecBot
SECBOTREPLAY Home › Report › ARQT

ARQT · Todd Watanabe, an officer of Arcutis Biotherapeutics, filed a Form 144…

Arcutis Biotherapeutics, Inc. · 144 filed Nov 2, 2026 at 17:29 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 2, 2026 at 17:29 ET

Todd Watanabe, an officer of Arcutis Biotherapeutics, filed a Form 144 on November 2, 2026, indicating intent to sell 4,377 shares of common stock with an approximate market value of $139,466. The shares were acquired via restricted stock vesting on November 1, 2026. This is a routine sale following vesting, representing a small fraction of the company's $4.0B market cap.

  • Insider Todd Watanabe (officer) filed Form 144 to sell 4,377 shares of common stock.
  • Estimated value of proposed sale: $139,466.
  • Shares acquired via restricted stock vesting on November 1, 2026.
  • Proposed sale date: November 2, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access